FENBENDAZOLE

FENBENDAZOLE was reported 107 times

FENBENDAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CANNABIS INTERACTION 1 0.0769
1 INCREASED LIVER STIFFNESS 1 0.0294
2 BLOOD ERYTHROPOIETIN INCREASED 1 0.0101
3 MALE GENITAL ATROPHY 1 0.0093
4 PRODUCT ADVERTISING ISSUE 1 0.0047
5 IMMUNE-MEDIATED MYASTHENIA GRAVIS 1 0.0031
6 PENILE ULCERATION 1 0.0031
7 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
8 BONE DENSITY INCREASED 1 0.0025
9 TACHYARRHYTHMIA 6 0.0024
10 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
11 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
12 DYSBIOSIS 1 0.0012
13 URGE INCONTINENCE 1 0.0011
14 POSTICTAL STATE 1 0.0010
15 FAECES PALE 2 0.0009
16 TORSADE DE POINTES 6 0.0008
17 SELF-MEDICATION 3 0.0007
18 RED BLOOD CELL COUNT INCREASED 2 0.0007
19 H1N1 INFLUENZA 1 0.0007
20 DIABETIC FOOT INFECTION 1 0.0007
21 HORDEOLUM 3 0.0007
22 HEPATIC NEOPLASM 2 0.0006
23 HYPERAMMONAEMIA 3 0.0006
24 GASTRIC DILATATION 1 0.0006
25 SEIZURE LIKE PHENOMENA 1 0.0006
26 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
27 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
28 NASAL SEPTUM DEVIATION 1 0.0005
29 BLOOD TESTOSTERONE INCREASED 1 0.0005
30 HAEMORRHAGE URINARY TRACT 1 0.0004
31 PELVIC FRACTURE 3 0.0004
32 IMMUNE-MEDIATED MYOSITIS 1 0.0004
33 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
34 PULMONARY PAIN 1 0.0003
35 HYPERCAPNIA 1 0.0003
36 MUSCULOSKELETAL CHEST PAIN 5 0.0003
37 BLOOD BLISTER 1 0.0003
38 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
39 NEOPLASM RECURRENCE 1 0.0003
40 ACUTE HEPATIC FAILURE 4 0.0003
41 CERVIX CARCINOMA 1 0.0003
42 MUSCLE FATIGUE 1 0.0002
43 POOR PERIPHERAL CIRCULATION 1 0.0002
44 BONE CANCER 1 0.0002
45 TONGUE DISCOLOURATION 1 0.0002
46 SUSPECTED OFF LABEL USE 1 0.0002
47 LOCALISED OEDEMA 1 0.0002
48 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
49 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
50 FAECES DISCOLOURED 4 0.0002
51 COAGULOPATHY 3 0.0002
52 PERIORBITAL SWELLING 1 0.0002
53 MOUTH SWELLING 1 0.0002
54 HYPERVENTILATION 1 0.0002
55 ENERGY INCREASED 1 0.0002
56 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
57 PIGMENTATION DISORDER 1 0.0002
58 SCOLIOSIS 1 0.0002
59 POISONING 2 0.0002
60 HAEMOGLOBIN ABNORMAL 1 0.0002
61 ERUCTATION 3 0.0002
62 UNRESPONSIVE TO STIMULI 4 0.0002
63 SOMNAMBULISM 1 0.0002
64 WRONG PRODUCT ADMINISTERED 1 0.0001
65 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
66 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
67 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
68 FAECES SOFT 1 0.0001
69 ACIDOSIS 1 0.0001
70 DRUG-INDUCED LIVER INJURY 4 0.0001
71 BLOOD PRESSURE FLUCTUATION 3 0.0001
72 SECOND PRIMARY MALIGNANCY 1 0.0001
73 EOSINOPHIL COUNT INCREASED 1 0.0001
74 MUSCLE STRAIN 1 0.0001
75 JAUNDICE 3 0.0001
76 LOSS OF LIBIDO 1 0.0001
77 FREQUENT BOWEL MOVEMENTS 3 0.0001
78 NERVE COMPRESSION 1 0.0001
79 HEPATIC STEATOSIS 2 0.0001
80 HEPATIC ENCEPHALOPATHY 1 0.0001
81 HOT FLUSH 8 0.0001
82 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
83 HEPATOMEGALY 1 0.0001
84 URINARY INCONTINENCE 3 0.0001
85 MOTOR DYSFUNCTION 1 0.0001
86 INITIAL INSOMNIA 1 0.0001
87 PRODUCT ODOUR ABNORMAL 1 0.0001
88 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
89 BLOOD GLUCOSE FLUCTUATION 1 0.0001
90 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
91 HEPATOTOXICITY 2 0.0001
92 GLOSSODYNIA 2 0.0001
93 CHROMATURIA 2 0.0001
94 EYE INFECTION 1 0.0001
95 FLATULENCE 5 0.0001
96 ENCEPHALOPATHY 2 0.0001
97 INJECTION SITE MASS 3 0.0001
98 PULMONARY CONGESTION 1 0.0001
99 BLOOD BILIRUBIN INCREASED 2 0.0001
100 LIMB INJURY 2 0.0001
101 OSTEOPOROSIS 3 0.0001
102 BLOOD TEST ABNORMAL 1 0.0001
103 INTENTIONAL DOSE OMISSION 2 0.0001
104 HYPERSOMNIA 2 0.0001
105 PULMONARY MASS 1 0.0001
106 THYROID DISORDER 1 0.0001
107 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
108 SCIATICA 1 0.0001
109 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
110 SENSORY DISTURBANCE 1 0.0001
111 METASTASES TO BONE 1 0.0001
112 ANGER 2 0.0001
113 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
114 MUSCULOSKELETAL DISCOMFORT 1 0.0001
115 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
116 HEAD DISCOMFORT 1 0.0001
117 GOUT 1 0.0001
118 TOOTHACHE 1 0.0001
119 HEPATIC CIRRHOSIS 1 0.0001
120 NEUROPATHY PERIPHERAL 5 0.0001
121 DYSPHONIA 3 0.0001
122 KIDNEY INFECTION 1 0.0001
123 DISORIENTATION 2 0.0001
124 STOMATITIS 3 0.0000
125 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
126 PULMONARY HYPERTENSION 1 0.0000
127 EATING DISORDER 1 0.0000
128 IRRITABLE BOWEL SYNDROME 1 0.0000
129 LIVER FUNCTION TEST INCREASED 1 0.0000
130 RHINORRHOEA 3 0.0000
131 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
132 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
133 RASH MACULO-PAPULAR 1 0.0000
134 LOCALISED INFECTION 1 0.0000
135 HYPOGLYCAEMIA 2 0.0000
136 PRESYNCOPE 1 0.0000
137 LIVER INJURY 1 0.0000
138 ERECTILE DYSFUNCTION 1 0.0000
139 SKIN ULCER 1 0.0000
140 HAEMATOMA 1 0.0000
141 ABDOMINAL DISTENSION 4 0.0000
142 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
143 INJECTION SITE BRUISING 3 0.0000
144 SKIN LESION 1 0.0000
145 ABNORMAL DREAMS 1 0.0000
146 FEELING COLD 1 0.0000
147 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
148 PAIN IN JAW 1 0.0000
149 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
150 ANGINA PECTORIS 1 0.0000
151 SEIZURE 4 0.0000
152 INTENTIONAL PRODUCT MISUSE 3 0.0000
153 RESPIRATORY DISORDER 1 0.0000
154 BLOOD POTASSIUM DECREASED 1 0.0000
155 LACRIMATION INCREASED 1 0.0000
156 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
157 LIMB DISCOMFORT 1 0.0000
158 MOOD SWINGS 1 0.0000
159 METABOLIC ACIDOSIS 1 0.0000
160 AMNESIA 2 0.0000
161 STAPHYLOCOCCAL INFECTION 1 0.0000
162 BACK PAIN 7 0.0000
163 LIP SWELLING 1 0.0000
164 ABDOMINAL DISCOMFORT 5 0.0000
165 FLUSHING 3 0.0000
166 HAEMATURIA 1 0.0000
167 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
168 MUSCLE SPASMS 5 0.0000
169 WEIGHT INCREASED 6 0.0000
170 ASTHENIA 10 0.0000
171 DYSPNOEA EXERTIONAL 1 0.0000
172 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
173 DECREASED APPETITE 6 0.0000
174 FATIGUE 20 0.0000
175 ALOPECIA 5 0.0000
176 ABNORMAL BEHAVIOUR 1 0.0000
177 DYSKINESIA 1 0.0000
178 POLLAKIURIA 1 0.0000
179 TOXICITY TO VARIOUS AGENTS 4 0.0000
180 INSOMNIA 6 0.0000
181 TACHYCARDIA 2 0.0000
182 THERAPY NON-RESPONDER 1 0.0000
183 NO ADVERSE EVENT 4 0.0000
184 NEPHROLITHIASIS 1 0.0000
185 SKIN DISCOLOURATION 1 0.0000
186 CHEST PAIN 4 0.0000
187 HYPERSENSITIVITY 4 0.0000
188 RENAL DISORDER 1 0.0000
189 BLOOD CHOLESTEROL INCREASED 1 0.0000
190 PRODUCTIVE COUGH 1 0.0000
191 DIARRHOEA 13 0.0000
192 SYNCOPE 2 0.0000
193 ACUTE KIDNEY INJURY 3 0.0000
194 CHEST DISCOMFORT 2 0.0000
195 THERAPY CESSATION 1 0.0000
196 HAEMOGLOBIN DECREASED 2 0.0000
197 ABDOMINAL PAIN UPPER 4 0.0000
198 INFLAMMATION 1 0.0000
199 DRUG INTERACTION 3 0.0000
200 PLATELET COUNT DECREASED 2 0.0000
201 CONSTIPATION 4 0.0000
202 ANAPHYLACTIC REACTION 1 0.0000
203 WEIGHT DECREASED 5 0.0000
204 NECK PAIN 1 0.0000
205 THROMBOCYTOPENIA 2 0.0000
206 BLISTER 1 0.0000
207 MUSCULAR WEAKNESS 2 0.0000
208 PALPITATIONS 2 0.0000
209 BONE PAIN 1 0.0000
210 SURGERY 1 0.0000
211 NASAL CONGESTION 1 0.0000
212 FEELING ABNORMAL 4 0.0000
213 JOINT SWELLING 2 0.0000
214 OEDEMA PERIPHERAL 2 0.0000
215 OFF LABEL USE 14 0.0000
216 PRURITUS 6 0.0000
217 FEBRILE NEUTROPENIA 1 0.0000
218 FALL 5 0.0000
219 HYPOTENSION 3 0.0000
220 HEPATIC ENZYME INCREASED 1 0.0000
221 ARTHRALGIA 6 0.0000
222 HEADACHE 9 0.0000
223 BURNING SENSATION 1 0.0000
224 DYSPNOEA 8 0.0000
225 RESPIRATORY FAILURE 1 0.0000
226 PRODUCT DOSE OMISSION ISSUE 4 0.0000
227 PAIN IN EXTREMITY 4 0.0000
228 EPISTAXIS 1 0.0000
229 UNEVALUABLE EVENT 1 0.0000
230 PERIPHERAL SWELLING 2 0.0000
231 ABDOMINAL PAIN 3 0.0000
232 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
233 TREATMENT FAILURE 1 0.0000
234 SKIN EXFOLIATION 1 0.0000
235 MYALGIA 2 0.0000
236 BALANCE DISORDER 1 0.0000
237 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
238 COVID-19 2 0.0000
239 ADVERSE DRUG REACTION 1 0.0000
240 NASOPHARYNGITIS 2 0.0000
241 PRODUCT USE ISSUE 2 0.0000
242 PULMONARY EMBOLISM 1 0.0000
243 CONTUSION 1 0.0000
244 DYSPEPSIA 1 0.0000
245 NAUSEA 8 0.0000
246 DIZZINESS 5 0.0000
247 CONDITION AGGRAVATED 3 0.0000
248 INJECTION SITE PAIN 3 0.0000
249 ILLNESS 1 0.0000
250 HYPERTENSION 2 0.0000
251 PNEUMONIA 3 0.0000
252 MALAISE 4 0.0000
253 VOMITING 4 0.0000
254 EMOTIONAL DISTRESS 1 0.0000
255 PAIN 5 0.0000
256 VISION BLURRED 1 0.0000
257 ANXIETY 2 0.0000
258 INFECTION 1 0.0000
259 HYPOAESTHESIA 1 0.0000
260 BLOOD PRESSURE INCREASED 1 0.0000
261 HOSPITALISATION 1 0.0000
262 URTICARIA 1 0.0000
263 CEREBROVASCULAR ACCIDENT 1 0.0000
264 URINARY TRACT INFECTION 1 0.0000
265 OVERDOSE 1 0.0000
266 RASH 2 0.0000
267 DEPRESSION 1 0.0000
268 INCORRECT DOSE ADMINISTERED 1 0.0000
269 DRUG INEFFECTIVE 5 0.0000
270 COUGH 1 0.0000
271 DEATH 2 0.0000